Search clinical trials for: AT13387 and Imatinib
Total 269669 results
-
National Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Recurrent...United States
-
Astex Pharmaceuticals, Inc.CompletedGastrointestinal Stromal Tumor (GIST)United States
-
Astex Pharmaceuticals, Inc.CompletedMetastatic Solid TumorsUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedUnresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedTriple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal... and other conditions
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.UnknownNeoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-Small-Cell LungChina
-
Xiangya Hospital of Central South UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingGastrointestinal Stromal TumorsChina
-
Astex Pharmaceuticals, Inc.CompletedNon-small Cell Lung Cancer(NSCLC)United States, Korea, Republic of, Spain, France, Canada
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
Scandinavian Sarcoma GroupCompleted
-
Sarit AssoulineNovartisRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia in Remission | Chronic Myeloid Leukemia, BCR/ABL-PositiveCanada
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myeloid LeukemiaChina
-
Seoul St. Mary's HospitalNovartisUnknownChronic Myeloid LeukemiaKorea, Republic of
-
M.D. Anderson Cancer CenterNovartisCompletedGastrointestinal Stromal TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma | Skin NeoplasmsUnited States
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Novartis PharmaceuticalsCompletedPulmonary Arterial HypertensionAustria, Germany, United States, United Kingdom
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
Dr. Jurjan AmanExvastat Ltd.; Simbec-Orion Group; KABS laboratoriesTerminatedCovid19 | Endothelial Dysfunction | Acute Respiratory Distress Syndrome | ARDS | Pulmonary EdemaNetherlands
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsUnited States, France, Belgium, Germany
-
M.D. Anderson Cancer CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedLeukemia, Myeloid, ChronicUnited States
-
Poitiers University HospitalNovartis; Roche Pharma AG; Ministry of Health, FranceCompleted
-
Samsung Medical CenterActive, not recruitingAdvanced, Refractory CancerKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Gastrointestinal Stromal TumorsItaly
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownCarcinoma, Adenoid Cystic | Cancer of the Head and NeckFrance
-
Hospices Civils de LyonUnknownAcute Lymphocytic LeukemiaFrance
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsNot yet recruitingRare Malignant Neoplasm
-
PETHEMA FoundationRecruitingAcute Lymphoblastic Leukemia Ph PositiveSpain
-
Yonsei UniversityCompletedFibromatosisKorea, Republic of
-
St. Justine's HospitalTerminatedPlexiform NeurofibromasCanada
-
CttqRuijin HospitalUnknown
-
NovartisCompletedChronic Myelogenous Leukemia in Chronic Phase
-
NovartisCompletedSeasonal Allergic RhinitisUnited Kingdom
-
Asan Medical CenterActive, not recruitingGastrointestinal Stromal TumorsKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Myeloid LeukaemiaItaly
-
Centre Oscar LambretNovartis; National Cancer Institute, FranceTerminated
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedAcute Lymphoblastic LeukemiaItaly
-
Azienda Ospedaliera Universitaria PoliclinicoUniversità Politecnica delle MarcheUnknown
-
Central European Leukemia Study GroupUnknown
-
University of PittsburghNovartisCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Agnogenic Myeloid MetaplasiaUnited States
-
Institut BergoniéNovartisTerminatedLeukemia, Myeloid, Chronic-PhaseFrance
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.Recruiting
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, Canada
-
University Hospital, BordeauxCompleted